SAVIMS

April 2021

COVID-19, Covid-19 vaccines, Ethics, Genetic vaccines, Other scientific evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Merriam-Webster Updates Definition of “Vaccine”

Reference: Mair, V. (2021, April 30). Merriam-Webster gives “vaccine” a new definition. Language Log. Retrieved from https://languagelog.ldc.upenn.edu/nll/?p=50886 Summary: In a recent post, Victor Mair discusses an update to the definition of “vaccine” by Merriam-Webster. While traditional definitions describe vaccines as preparations of weakened or killed pathogens, the new entry expands this definition significantly. It now […]

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Ethics, Other scientific evidence, Reference Library, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Monitoring the Effectiveness of the Ad26.COV2.S COVID-19 Vaccine in South African Healthcare Workers

Reference: South African Medical Research Council. (2021). Sisonke Protocol Version 4.4 dated 29 Apr 2021. Summary: The Sisonke Protocol is an open-label, single-arm phase 3B study aimed at evaluating the effectiveness of the Ad26.COV2.S COVID-19 vaccine among healthcare workers in South Africa. This study involves approximately 500,000 healthcare workers aged 18 and older, who will

COVID-19, Covid-19 vaccines, Genetic vaccines, Peer-reviewed evidence, Resource Type, Vaccines, Viral illnesses

The Johnson & Johnson Vaccine for COVID-19

Reference: Livingston, E. H., Malani, P. N., & Creech, C. B. (2021). The Johnson & Johnson vaccine for COVID-19. JAMA Patient Page. https://doi.org/10.1001/jama.2021.2927 Summary: The Johnson & Johnson COVID-19 vaccine employs a unique approach using a modified adenovirus to induce an immune response without causing infection. Unlike mRNA vaccines from Pfizer and Moderna, which require

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Analysis of Adverse Drug Reactions for Covid-19 Vaccines

Reference: VigiAccess. (2021). VigiAccess™. Retrieved from https://who-umc.org Summary: VigiAccess provides a comprehensive overview of adverse drug reactions (ADRs) associated with Covid-19 vaccines, highlighting a total of 2,183,912 reports. The data illustrates the geographical distribution of ADRs, with significant counts reported across continents such as the Americas, Europe, and Asia. The analysis categorises ADRs into various

COVID-19, Ivermectin, Other scientific evidence, Treatment, Viral illnesses

Legal Victory for Ivermectin Access in South Africa

Reference: The NewERA. (2021, April 8). SAHPRA destroyed in court – Ivermectin available. Summary: On 8 April 2021, a significant court ruling declared that the South African Health Products Regulatory Authority (SAHPRA) could no longer restrict access to Ivermectin, a treatment believed to help with HIV and COVID-19. The High Court found SAHPRA’s actions to

Scroll to Top